Mörck, B., Pullerits, R., Geijer, M., Bremell, T., & Forsblad-d'Elia, H. Infliximab Dose Reduction Sustains the Clinical Treatment Effect in Active HLAB27 Positive Ankylosing Spondylitis: A Two-Year Pilot Study. Wiley.
Chicago Style (17th ed.) CitationMörck, Boel, Rille Pullerits, Mats Geijer, Tomas Bremell, and Helena Forsblad-d'Elia. Infliximab Dose Reduction Sustains the Clinical Treatment Effect in Active HLAB27 Positive Ankylosing Spondylitis: A Two-Year Pilot Study. Wiley.
MLA (9th ed.) CitationMörck, Boel, et al. Infliximab Dose Reduction Sustains the Clinical Treatment Effect in Active HLAB27 Positive Ankylosing Spondylitis: A Two-Year Pilot Study. Wiley.
Warning: These citations may not always be 100% accurate.